Catalent Pharma Solutions, Inc. - Strategic SWOT Analysis Review
Catalent Pharma Solutions, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Catalent Pharma Solutions, Inc. (Catalent) is a provider of development solutions and advanced delivery technologies for the global biotechnology, pharmaceutical and consumer health industries. It is a wholly-owned subsidiary of PTS Intermediate Holdings LLC. The company offers a comprehensive range of drug and biologic development services, delivery technologies, supply and packaging solutions for its customers to bring more products and better treatments to the market. The company operates in three businesses, namely, Development and Clinical Services, Oral Technologies and Medication Delivery Solutions.
Catalent Pharma Solutions, Inc. Key Recent Developments
Sep 09, 2013: Catalent Names President of Asia Pacific
Jul 16, 2013: Advances in Modified & Controlled Release Presented by Catalent Experts at 40th Annual CRS Meeting
Jul 08, 2013: Catalent Creates New Advanced Delivery Technologies Business Unit
Jun 20, 2013: Catalent Officially Launches New Capabilities At CPhI China
Jun 12, 2013: Catalent Pharma Announces $35m Expansion Of Controlled Release Manufacturing Facility At Winchester, To Create 90 Jobs
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.